Trials / Recruiting
RecruitingNCT05922540
a Cohort Study of Ischemic Cerebrovascular Disease
a Prospective, Multicenter Cohort Study of Ischemic Cerebrovascular Disease
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- Xiangya Hospital of Central South University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study aims to establish a multicenter, large-scale, prospective cohort of patients with ischemic stroke. Various biological samples such as blood, feces, and urine are collected to identify biomarkers associated with ischemic stroke. By integrating demographic information, clinical indicators, imaging parameters, and biomarker parameters, the study aims to develop risk assessment, early warning, and prognosis prediction models. Additionally, the study aims to identify key genes and explore relevant signaling pathways related to ischemic stroke.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Intravenous thrombolysis | Intravenous thrombolysis with alteplase within the time window of stroke onset in stroke patients |
Timeline
- Start date
- 2022-11-01
- Primary completion
- 2026-11-01
- Completion
- 2027-11-01
- First posted
- 2023-06-28
- Last updated
- 2023-06-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05922540. Inclusion in this directory is not an endorsement.